AMN

SEC source: 0001209191-18-039128 · doc4.xml · nonDerivative · entry 1

SALKA SUSAN R · CIK 0001158584 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 165,742

F1 · kind: The sale of 20,000 shares of AMN Common Stock reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · price: The price reported in this row represents a weighted average price of $60.1698 per share. These shares were sold in multiple transactions at prices ranging from $60.00 to $60.40, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-18-038738 · doc4.xml · nonDerivative · entry 1

Scott Brian M. · CIK 0001510242 · CFO/CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,365

F1 · kind: The sale of 12,500 shares of AMN Common Stock reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · price: The price reported in this row represents a weighted average price of $58.5761 per share. These shares were sold in multiple transactions at prices ranging from $58.20 to $58.90, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-18-032148 · doc4.xml · nonDerivative · entry 1

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,952

F1 · price: The price reported in this row represents a weighted average price of $58.7314 per share. These shares were sold in multiple transactions at prices ranging from $58.70 to $58.75, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-18-029588 · doc4.xml · derivative · entry 7

HARRIS R JEFFREY · CIK 0001183645 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 8,224 shares

Expires 2019-04-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The SSARs set forth in this row were granted on April 9, 2009 pursuant to the AMN Healthcare Equity Plan and vested on the one year anniversary of the grant date.

SEC source: 0001209191-18-030208 · doc4.xml · nonDerivative · entry 1

SALKA SUSAN R · CIK 0001158584 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 185,742

F1 · kind: The sale of 20,376 shares of Common Stock reported in this row was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · price: The price reported in this row represents a weighted average price of $56.1861 per share. These shares were sold in multiple transactions at prices ranging from $56.35 to $56.00, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-18-029363 · doc4.xml · nonDerivative · entry 2

SALKA SUSAN R · CIK 0001158584 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 206,118

F2 · kind: The sale of 31,907 shares of Common Stock reported in this row was also effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F3 · price: The price reported in this row represents a weighted average price of $54.6306 per share. These shares were sold in multiple transactions at prices ranging from $54.00 to $55.00, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-18-029588 · doc4.xml · nonDerivative · entry 6

HARRIS R JEFFREY · CIK 0001183645 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,227

F4 · kind: The reporting person transferred 3,490 shares of AMN Common Stock as a gift to charity.

SEC source: 0001209191-18-029588 · doc4.xml · nonDerivative · entry 5

HARRIS R JEFFREY · CIK 0001183645 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,717

F3 · price: The price reported in this row represents a weighted average price of $54.6144 per share. These shares were sold in multiple transactions at prices ranging from $54.55 to $54.675, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-18-029588 · doc4.xml · nonDerivative · entry 4

HARRIS R JEFFREY · CIK 0001183645 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,993

SEC source: 0001209191-18-029588 · doc4.xml · nonDerivative · entry 3

HARRIS R JEFFREY · CIK 0001183645 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,013

F2 · price: The price reported in this row represents a weighted average price of $54.2408 per share. These shares were sold in multiple transactions at prices ranging from $54.15 to $54.45, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-18-029588 · doc4.xml · nonDerivative · entry 2

HARRIS R JEFFREY · CIK 0001183645 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 87,241

F1 · shares: A Stock-Settled Appreciation Right ("SSAR") entitles the Grantee to the right to receive shares of AMN's Common Stock ("Stock") having a value equal to the excess of the Fair Market Value of the closing price of the Stock on the trading day prior to the date of exercise over the Exercise Price multiplied by the number of SSARs exercised. This number set forth in this row represents the difference between the number of SSARs exercised (8,224) and the number of shares of Stock issued as a result of the exercise (7,276).

SEC source: 0001209191-18-029588 · doc4.xml · nonDerivative · entry 1

HARRIS R JEFFREY · CIK 0001183645 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 88,189

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-18-029363 · doc4.xml · nonDerivative · entry 1

SALKA SUSAN R · CIK 0001158584 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 238,025

F1 · kind: The sale of 45 shares of Common Stock reported in this row was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

SEC source: 0001209191-18-025741 · doc4.xml · derivative · entry 3

WHEAT DOUGLAS D · CIK 0001158599 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,365 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F6 · derivative.exercise_date: The RSUs identified in this row were granted on April 18, 2017 and vest on the earlier of (i) the one year anniversary of the grant date or (ii) the date of the Company's 2018 Annual Meeting of Shareholders. The Company's 2018 Annual Meeting of Shareholders was held on April 18, 2018. Accordingly, the number of RSUs identified in this row (i.e., 3,365) vested on April 18, 2018.

F4 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-18-025741 · doc4.xml · derivative · entry 2

WHEAT DOUGLAS D · CIK 0001158599 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,153 shares

Expires not disclosed

F2 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F3 · derivative.exercise_date: The RSUs identified in this row were granted on April 18, 2018 and vest on the earlier of (i) the one year anniversary of the grant date or (ii) the date of the Company's 2019 Annual Meeting of Shareholders.

F4 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-18-025741 · doc4.xml · nonDerivative · entry 1

WHEAT DOUGLAS D · CIK 0001158599 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,365

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units ("RSUs").

SEC source: 0001209191-18-025737 · doc4.xml · derivative · entry 1

STERN ANDREW M · CIK 0001158585 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,153 shares

Expires not disclosed

F1 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F2 · derivative.exercise_date: The RSUs identified in this row were granted on April 18, 2018 and vest on the earlier of (i) the one year anniversary of the grant date or (ii) the date of the Company's 2019 Annual Meeting of Shareholders. At the reporting person's irrevocable election, the number of RSUs identified in this row (i.e., 2,153) settle on the date of the director's termination of service with the Company.

F3 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-18-025739 · doc4.xml · derivative · entry 3

Weaver Paul E · CIK 0001363498 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,365 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F6 · derivative.exercise_date: The RSUs identified in this row were granted on April 18, 2017 and vest on the earlier of (i) the one year anniversary of the grant date or (ii) the date of the Company's 2018 Annual Meeting of Shareholders. The Company's 2018 Annual Meeting of Shareholders was held on April 18, 2018. Accordingly, the number of RSUs identified in this row (i.e., 3,365) vested on April 18, 2018.

F4 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-18-025739 · doc4.xml · derivative · entry 2

Weaver Paul E · CIK 0001363498 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,153 shares

Expires not disclosed

F2 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F3 · derivative.exercise_date: The RSUs identified in this row were granted on April 18, 2018 and vest on the earlier of (i) the one year anniversary of the grant date or (ii) the date of the Company's 2019 Annual Meeting of Shareholders.

F4 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-18-025739 · doc4.xml · nonDerivative · entry 1

Weaver Paul E · CIK 0001363498 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,022

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units ("RSUs").

SEC source: 0001209191-18-025728 · doc4.xml · derivative · entry 1

JOHNS MICHAEL M E · CIK 0001221096 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,153 shares

Expires not disclosed

F1 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F2 · derivative.exercise_date: The RSUs identified in this row were granted on April 18, 2018 and vest on the earlier of (i) the one year anniversary of the grant date or (ii) the date of the Company's 2019 Annual Meeting of Shareholders. At the reporting person's irrevocable election, the number of RSUs identified in this row (i.e., 2,153) settle on the date of the director's termination of service with the Company.

F3 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-18-025733 · doc4.xml · derivative · entry 3

Marsh Martha H. · CIK 0001500281 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,365 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F6 · derivative.exercise_date: The RSUs identified in this row were granted on April 18, 2017 and vest on the earlier of (i) the one year anniversary of the grant date or (ii) the date of the Company's 2018 Annual Meeting of Shareholders. The Company's 2018 Annual Meeting of Shareholders was held on April 18, 2018. Accordingly, the number of RSUs identified in this row (i.e., 3,365) vested on April 18, 2018.

F4 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-18-025733 · doc4.xml · derivative · entry 2

Marsh Martha H. · CIK 0001500281 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,153 shares

Expires not disclosed

F2 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F3 · derivative.exercise_date: The RSUs identified in this row were granted on April 18, 2018 and vest on the earlier of (i) the one year anniversary of the grant date or (ii) the date of the Company's 2019 Annual Meeting of Shareholders.

F4 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-18-025733 · doc4.xml · nonDerivative · entry 1

Marsh Martha H. · CIK 0001500281 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,363

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units ("RSUs").

SEC source: 0001209191-18-025705 · doc4.xml · derivative · entry 3

HARRIS R JEFFREY · CIK 0001183645 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,365 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F6 · derivative.exercise_date: The RSUs identified in this row were granted on April 18, 2017 and vest on the earlier of (i) the one year anniversary of the grant date or (ii) the date of the Company's 2018 Annual Meeting of Shareholders. The Company's 2018 Annual Meeting of Shareholders was held on April 18, 2018. Accordingly, the number of RSUs identified in this row (i.e., 3,365) vested on April 18, 2018.

F4 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-18-025705 · doc4.xml · derivative · entry 2

HARRIS R JEFFREY · CIK 0001183645 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,153 shares

Expires not disclosed

F2 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F3 · derivative.exercise_date: The RSUs identified in this row were granted on April 18, 2018 and vest on the earlier of (i) the one year anniversary of the grant date or (ii) the date of the Company's 2019 Annual Meeting of Shareholders.

F4 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-18-025705 · doc4.xml · nonDerivative · entry 1

HARRIS R JEFFREY · CIK 0001183645 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,965

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units ("RSUs").

SEC source: 0001209191-18-025703 · doc4.xml · derivative · entry 3

FOLETTA MARK G · CIK 0001236389 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,365 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F6 · derivative.exercise_date: The RSUs identified in this row were granted on April 18, 2017 and vest on the earlier of (i) the one year anniversary of the grant date or (ii) the date of the Company's 2018 Annual Meeting of Shareholders. The Company's 2018 Annual Meeting of Shareholders was held on April 18, 2018. Accordingly, the number of RSUs identified in this row (i.e., 3,365) vested on April 18, 2018.

F4 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-18-025703 · doc4.xml · derivative · entry 2

FOLETTA MARK G · CIK 0001236389 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,153 shares

Expires not disclosed

F2 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F3 · derivative.exercise_date: The RSUs identified in this row were granted on April 18, 2018 and vest on the earlier of (i) the one year anniversary of the grant date or (ii) the date of the Company's 2019 Annual Meeting of Shareholders.

F4 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-18-025703 · doc4.xml · nonDerivative · entry 1

FOLETTA MARK G · CIK 0001236389 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,890

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units ("RSUs").

SEC source: 0001209191-18-012765 · doc4.xml · nonDerivative · entry 1

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,952

F1 · kind: The sale of 7,345 shares of Common Stock reported in this row was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · price: The price reported in this row represents a weighted average price of $36.2701 per share. These shares were sold in multiple transactions at prices ranging from $56.60 to $57.10, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-18-011666 · doc4.xml · nonDerivative · entry 7

Henderson Ralph · CIK 0001410701 · Pres., Prof. Svc. & Staffing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,833

F4 · kind: The sale of 10,178 shares of Common Stock reported in this row was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F5 · price: The price reported in this row represents a weighted average price of $56.20 per share. These shares were sold in multiple transactions at prices ranging from $56.12 to $56.27, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-18-012628 · doc4.xml · derivative · entry 3

Weaver Paul E · CIK 0001363498 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,168 shares

Expires 2018-04-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The Stock Appreciation Rights set forth in this row were granted on April 8, 2008 and vested over three years on the anniversary of the grant date in increments of 33%, 34% and 33%, respectively.

SEC source: 0001209191-18-012628 · doc4.xml · nonDerivative · entry 2

Weaver Paul E · CIK 0001363498 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,657

F1 · shares: A Stock-Settled Appreciation Right ("SSAR") entitles the Grantee to the right to receive shares of the Company's Common Stock ("Stock") having a value equal to the excess of the Fair Market Value of the closing price of the Stock on the trading day prior to the date of exercise over the Exercise Price multiplied by the number of SSARs exercised. This number set forth in this row represents the difference between the number of SSARs exercised (5,168) and the number of shares of Stock issued as a result of the exercise (3,688).

SEC source: 0001209191-18-012628 · doc4.xml · nonDerivative · entry 1

Weaver Paul E · CIK 0001363498 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,137

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-18-012680 · doc4.xml · derivative · entry 3

HARRIS R JEFFREY · CIK 0001183645 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,168 shares

Expires 2018-04-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The Stock Appreciation Rights set forth in this row were granted on April 8, 2008 and vested over three years on the anniversary of the grant date in increments of 33%, 34% and 33%, respectively.

SEC source: 0001209191-18-012680 · doc4.xml · nonDerivative · entry 2

HARRIS R JEFFREY · CIK 0001183645 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,600

F1 · shares: A Stock-Settled Appreciation Right ("SSAR") entitles the Grantee to the right to receive shares of the Company's Common Stock ("Stock") having a value equal to the excess of the Fair Market Value of the closing price of the Stock on the trading day prior to the date of exercise over the Exercise Price multiplied by the number of SSARs exercised. This number set forth in this row represents the difference between the number of SSARs exercised (5,168) and the number of shares of Stock issued as a result of the exercise (3,688).

SEC source: 0001209191-18-012680 · doc4.xml · nonDerivative · entry 1

HARRIS R JEFFREY · CIK 0001183645 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 78,080

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-18-063508 · doc4.xml · nonDerivative · entry 1

SALKA SUSAN R · CIK 0001158584 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 143,789

F1 · kind: The reporting person transferred 10,000 shares of AMN Common Stock as a gift to charity.

SEC source: 0001209191-18-011655 · doc4.xml · nonDerivative · entry 7

Scott Brian M. · CIK 0001510242 · CFO/CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,865

F4 · kind: The sale of 3,634 shares of Common Stock reported in this row was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F5 · price: The price reported in this row represents a weighted average price of $55.0318 per share. These shares were sold in multiple transactions at prices ranging from $55.00 to $55.05, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-18-011687 · doc4.xml · derivative · entry 8

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,470

Underlying: Common Stock · 1,217 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: The RSUs identified in this row were granted pursuant to the AMN Healthcare Equity Plan. Each RSU represents a contingent right to receive one share of Common Stock.

F7 · derivative.exercise_date: The RSUs identified in this row were granted on January 4, 2017 and vest on the third anniversary of the grant date, provided, however, the RSUs shall vest on an accelerated basis thirteen months after the grant date, in the incremental amount of 33%, should the Company achieve or exceed a certain specified EBITDA target for the 2017 fiscal year and on the second anniversary of the grant date, in the amount of 34%, should the Company achieve or exceed the specified EBITDA target for the 2018 fiscal year.

F6 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-18-011687 · doc4.xml · derivative · entry 7

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,531

Underlying: Common Stock · 1,577 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: The RSUs identified in this row were granted pursuant to the AMN Healthcare Equity Plan. Each RSU represents a contingent right to receive one share of Common Stock.

F5 · derivative.exercise_date: The RSUs identified in this row were granted on January 5, 2016 and vest on the third anniversary of the grant date, provided, however, the RSUs shall vest on an accelerated basis thirteen months after the grant date, in the incremental amount of 33%, should the Company achieve or exceed a certain specified earnings before interest, taxes, depreciation and amortization (EBITDA) target for the 2016 fiscal year, and on the second anniversary of the grant date, in the amount of 34%, should the Company achieve or exceed the specified EBITDA target for the 2017 fiscal year.

F6 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-18-011687 · doc4.xml · nonDerivative · entry 6

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,297

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-18-011687 · doc4.xml · nonDerivative · entry 5

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,900

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · kind: Common Stock acquired on the vesting of Restricted Stock Units ("RSUs").

SEC source: 0001209191-18-011687 · doc4.xml · nonDerivative · entry 4

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,683

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-18-011687 · doc4.xml · nonDerivative · entry 3

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,464

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · kind: Common Stock acquired on the vesting of Restricted Stock Units ("RSUs").

SEC source: 0001209191-18-011687 · doc4.xml · nonDerivative · entry 2

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,887

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-18-011687 · doc4.xml · nonDerivative · entry 1

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,505

F1 · kind: The acquisition of Common Stock set forth in this row resulted from the vesting of a Performance Restricted Stock Unit ("PRSU") award granted by the Company on January 5, 2015. The ultimate number of PRSUs that could have been earned and vested under this award depended on the Company achieving or exceeding, on a consolidated basis, a certain specified adjusted earnings before interest, taxes, depreciation and amortization, divided by gross revenue and expressed as a percentage ("Adjusted EBITDA Margin") as of December 31, 2017 for the one-year period beginning on January 1, 2017 and ended December 31, 2017. The maximum amount of PRSUs for this award were deemed earned and vested.

SEC source: 0001209191-18-011666 · doc4.xml · derivative · entry 9

Henderson Ralph · CIK 0001410701 · Pres., Prof. Svc. & Staffing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,217

Underlying: Common Stock · 2,077 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_price: The RSUs identified in this row were granted pursuant to the AMN Healthcare Equity Plan. Each RSU represents a contingent right to receive one share of Common Stock.

F9 · derivative.exercise_date: The RSUs identified in this row were granted on January 4, 2017 and vest on the third anniversary of the grant date, provided, however, the RSUs shall vest on an accelerated basis thirteen months after the grant date, in the incremental amount of 33%, should the Company achieve or exceed a certain specified EBITDA target for the 2017 fiscal year and on the second anniversary of the grant date, in the amount of 34%, should the Company achieve or exceed the specified EBITDA target for the 2018 fiscal year.

F8 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-18-011666 · doc4.xml · derivative · entry 8

Henderson Ralph · CIK 0001410701 · Pres., Prof. Svc. & Staffing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,296

Underlying: Common Stock · 2,366 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_price: The RSUs identified in this row were granted pursuant to the AMN Healthcare Equity Plan. Each RSU represents a contingent right to receive one share of Common Stock.

F7 · derivative.exercise_date: The RSUs identified in this row were granted on January 5, 2016 and vest on the third anniversary of the grant date, provided, however, the RSUs shall vest on an accelerated basis thirteen months after the grant date, in the incremental amount of 33%, should the Company achieve or exceed a certain specified earnings before interest, taxes, depreciation and amortization (EBITDA) target for the 2016 fiscal year, and on the second anniversary of the grant date, in the amount of 34%, should the Company achieve or exceed the specified EBITDA target for the 2017 fiscal year.

F8 · derivative.expiration_date: RSUs do not have an expiration date.